Enterohepatic Transcription Factor CREB3L3 Protects Atherosclerosis via SREBP Competitive Inhibition.

Cell Mol Gastroenterol Hepatol · 2021 · PMC7900604 · PMID 33246135

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Consistent with a previous report, 16 LDLR −/− FGF21 −/− mice showed a trend of more severe development of atherosclerosis.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.